Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 431-434

  Capkin, Erhan ^a   Karkucak, Murat ^a   Kose, Muammer Muslim ^a   Çakmak, Vildan Altunayoǧlu ^a   Turkyilmaz, Aysegul Kucukali ^b   Tosun, Mehmet ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b Rize Education and Research Hospital   (Turkey)

Author keywords

Nerve conductions studies, ankylosing spondylitis; Neurological side effects; Peripheral demyelination neuropathy; Tumor necrosis factor (TNF )

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MOTOR NERVE CONDUCTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCORING SYSTEM; SEDIMENTATION RATE; SENSORY NERVE CONDUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NEURAL CONDUCTION; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857059686     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1677-x     Document Type: Article

References (20)

1. M Apostolaki M Armaka P Victoratos, et al. 2010 Cellular mechanisms of TNF function in models of inflammation and autoimmunity Curr Dir Autoimmun 11 1 26 20173385 10.1159/000289195 1:CAS:528:DC%2BC3cXnvFWms7o%3D
2. C Manuel Ramos A Roberto-Perez L Candido Diaz, et al. 2010 Autoimmune diseases induced by biological agents; A double-edged sword? Autoimmun Rev 9 188 193 10.1016/j.autrev.2009.10.003
3. JB Stubgen 2008 Tumor Necrosis Factor-α antagonists and neuropathy Muscle Nerve 37 281 292 18041052 10.1002/mus.20924 1:CAS:528: DC%2BD1cXjs1eqtLg%3D (Pubitemid 351304787)
4. C Kokona M Athanasia 2006 Anti-TNF-a Antibody Therapies in Autoimmune Diseases Curr Top Med Chem 6 14 1707
5. JM Ko AB Gottlieb JF Kerbleski 2009 Induction and exacerbation of psoriasis with TNF-α blockade therapy: a review and analysis of 127 cases J Dermatolog Treat 20 2 100 108 18923992 10.1080/09546630802441234 1:CAS:528:DC%2BD1MXlsVKltr8%3D
6. N Mohan ET Edwards TR Cupps, et al. 2001 Demyelination occurring during anti-tumornecrosis factor-therapy for inflammatory arthritides Arthritis Rheum 44 2862 2869 11762947 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0. CO;2-W 1:CAS:528:DC%2BD38XislCltA%3D%3D (Pubitemid 34016206)
7. M Ramos-Casals P Brito-Zeron S Munoz, et al. 2007 Autoimmune diseases induced by TNF targeted therapies: analysis of 233 cases Medicine 86 242 251 17632266 10.1097/MD.0b013e3181441a68 (Pubitemid 47067483)
8. WH Robinson MC Genovese LW Moreland 2001 Demyelinating and neurologic events reported in association with tumor necrosis factor-antagonism Arthritis Rheum 44 1977 1983 11592357 10.1002/1529-0131(200109)44:9<1977::AID- ART345>3.0.CO;2-6 1:CAS:528:DC%2BD3MXpt12lsbg%3D (Pubitemid 33644038)
9. OC Singer B Otto Steinmetz H, et al. 2004 Acute neuropathy with multiple conduction blocks after TNF-α monoclonal antibody therapy Neurology 63 1754 15534279 (Pubitemid 39507613)
10. H-P Hartung 1993 Immune-mediated demyelination Ann Neurol 33 563 567 8498835 10.1002/ana.410330602 1:STN:280:DyaK3s3ntVClsg%3D%3D (Pubitemid 23161875)
11. J Zhu E Mix H Link 1998 Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome J Neuroimmunol 84 40 52 9600707 10.1016/S0165-5728(97)00238-5 1:CAS:528:DyaK1cXhvFKisLc%3D (Pubitemid 28210448)
12. MK Sharief DA Ingram M Swash 1997 Circulating tumor necrosis factor-α correlates with electrodiagnostic abnormalities in Guillain-Barre syndrome Ann Neurol 42 68 73 9225687 10.1002/ana.410420112 1:STN:280: DyaK2szmvFWquw%3D%3D (Pubitemid 27304782)
13. HP Hartung S Jung G Stoll, et al. 1992 The role of inflammatory mediators in demyelinating disorders of the CNS and PNS J Neuroimmunol 40 10 197
14. G Said M Hontebeyrie-Joskowicz 1992 Nerve lesions induced by macrophage activation Res Immunol 143 589 599 1455050 10.1016/0923-2494(92)80040-R 1:STN:280:DyaK3s%2Foslygsg%3D%3D
15. PJ Kotyla B Sliwinska-Kotyla EJ Kucharz 2007 Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis Clin Rheumatol 26 1595 1596 17549580 10.1007/s10067-007-0657-3 (Pubitemid 47193589)
16. OH Gündüz MZ Kiralp L Ozçakar, et al. 2010 Nerve conduction studies in patients with ankylosing spondylitis J Natl Med Assoc 102 3 243 246 20355354
17. P Lozeron C Denier C Lacroix, et al. 2009 Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy Arch Neurol 66 4 490 497 19364934 10.1001/archneurol.2009.11
18. P Richette P Dieude J Damiano, et al. 2004 Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis J Rheumatol 31 81 2079
19. RS Tsang A Valdivieso-Garcia 2003 Pathogenesis of Guillain-Barre syndrome Expert Rev Anti Infect Ther 1 597 608 15482157 10.1586/14787210.1.4.597
20. C Richez P Blanco A Lagueny, et al. 2005 Neuropathy resembling CIDP in patients receiving tumornecrosis factor-α blockers Neurology 64 1468 1470 15851749 10.1212/01.WNL.0000158681.29117.8B 1:STN:280:DC%2BD2M3hslCjtg%3D%3D (Pubitemid 40570527)